Heat shock protein 90 (HSP90) is overexpressed in p16-negative oropharyngeal squamous cell carcinoma, and its inhibition in vitro potentiates the effects of chemoradiation

Title
Heat shock protein 90 (HSP90) is overexpressed in p16-negative oropharyngeal squamous cell carcinoma, and its inhibition in vitro potentiates the effects of chemoradiation
Authors
Keywords
HPV, Head neck cancer, HSP90, Ganetespib, Radiation therapy, Cisplatin
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 74, Issue 5, Pages 1015-1022
Publisher
Springer Nature
Online
2014-09-09
DOI
10.1007/s00280-014-2584-8

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now